While 15/16 control animals in which DN-ATF5 was turned off at the time of tumor induction developed tumors that expressed GFAP and ATF5, only 1/7 animals in which DN-ATF5 was on at the time of tumor induction developed a glioma. The gene discussed is GFAP; the disease is central nervous system cancer.